NCT03821311View on ClinicalTrials.gov

Investigating the Effect of Nasal High Flow Oxygen Therapy on Regional Lung Function

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

December 6, 2018

Primary Completion Date

June 18, 2019

Study Completion Date

June 18, 2019

Conditions
Chronic Obstructive Pulmonary DiseaseNasal High FlowDynamic Volumetric Computed Tomography
Interventions
RADIATION

Computed tomography

End-inspiratory/end-expiratory CT is repeated 3 times corresponding to the 3 studied conditions: At baseline, through expiratory resistive loading using an adjustable PEP mask, and after 5 min of nasal high flow therapy at 25 L/min.

Trial Locations (1)

38000

University Hospital Grenoble, Grenoble

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT03821311 - Investigating the Effect of Nasal High Flow Oxygen Therapy on Regional Lung Function | Biotech Hunter | Biotech Hunter